Long-term use of nonaspirin anti-inflammatory drugs (NSAIDs) is associated with an increased risk of renal cell cancer (RCC), according to a report in the Sept. issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Long-term use of nonaspirin anti-inflammatory drugs (NSAIDs) is associated with an increased risk of renal cell cancer (RCC), according to a report in the Sept. issue of Archives of Internal Medicine, one of the JAMA/Archives journals.